🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 19249H103
- Market Cap
- Mid Cap
- IPO
- 11/6/2014 · $13.50/share
Business: Coherus BioSciences, Inc. is a leading biologics platform company developing biosimilar therapeutics for global markets. As a pure play company in the biosimilar space, Coherus has the cutting-edge analytics, process science, and clinical and regulatory capabilities to move clinical candidates rapidly through the drug development pipeline. Led by an elite team of industry veterans who developed the first generation of biologics, Coherus has the scientific capabilities, scalable business model and financial infrastructure required to forge new paths in the fast-evolving biosimilars marketplace.
Company Contact
- CEO
- Dennis M. Lanfear
- CFO
- Bryan McMichael
- Headquarters
- 333 Twin Dolphin Drive, Suite 600, Redwood City, California 94065
- Phone
- 650-649-3530 · Toll-Free 800-794-5434
- Investor Relations
- David S. Arrington · 650-395-0196 · darrington@coherus.com